Mice deficient in pyruvate dehydrogenase kinase 4 are protected against acetaminophen-induced hepatotoxicity.

[1]  Robert A. Harris,et al.  Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis , 2019, Molecular Cancer Therapeutics.

[2]  H. Jaeschke,et al.  Acetaminophen Hepatotoxicity , 2019, Seminars in Liver Disease.

[3]  B. Fromenty,et al.  Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. , 2019, Advances in pharmacology.

[4]  Anna Trincone,et al.  Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease , 2018, BMC Medical Genomics.

[5]  H. Jaeschke,et al.  Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity , 2018, Archives of Toxicology.

[6]  Yulan Zhao,et al.  Loss of PDK4 switches the hepatic NF‐κB/TNF pathway from pro‐survival to pro‐apoptosis , 2018, Hepatology.

[7]  Robert A. Harris,et al.  PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels , 2018, Diabetes.

[8]  Congying Wang,et al.  Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis. , 2018, Biochemical and biophysical research communications.

[9]  H. Jaeschke,et al.  Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity , 2016, Archives of Toxicology.

[10]  H. Jaeschke,et al.  Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential , 2016, Redox biology.

[11]  N. Kaplowitz,et al.  c‐Jun N‐terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)‐dependent pathway leading to inactivation of intramitochondrial Src , 2016, Hepatology.

[12]  Mitchell R. McGill,et al.  Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase. , 2014, Toxicology and applied pharmacology.

[13]  B. Fromenty,et al.  Acetaminophen‐induced liver injury in obesity and nonalcoholic fatty liver disease , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[14]  J. Mauer,et al.  Loss of UCP2 Attenuates Mitochondrial Dysfunction without Altering ROS Production and Uncoupling Activity , 2014, PLoS genetics.

[15]  M. Hulver,et al.  The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility , 2014, Nutrition & Metabolism.

[16]  Mitchell R. McGill,et al.  Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis , 2013, Pharmaceutical Research.

[17]  Hartmut Jaeschke,et al.  Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. , 2012, Toxicology and applied pharmacology.

[18]  Mitchell R. McGill,et al.  Differences in Early Acetaminophen Hepatotoxicity between Obese ob/ob and db/db Mice , 2012, Journal of Pharmacology and Experimental Therapeutics.

[19]  F. Gonzalez,et al.  Peroxisome proliferator‐activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen‐induced liver toxicity , 2012, Hepatology.

[20]  William M. Lee.  Acute Liver Failure , 2012, Seminars in Respiratory and Critical Care Medicine.

[21]  N. Kaplowitz,et al.  c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice* , 2011, The Journal of Biological Chemistry.

[22]  R. Mukhopadhyaya,et al.  Uncoupling Protein 2 Negatively Regulates Mitochondrial Reactive Oxygen Species Generation and Induces Phosphatase-Mediated Anti-Inflammatory Response in Experimental Visceral Leishmaniasis , 2011, The Journal of Immunology.

[23]  H. Jaeschke,et al.  Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  H. Jaeschke,et al.  The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. , 2011, Toxicology and applied pharmacology.

[25]  H. Jaeschke,et al.  c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. , 2010, Toxicology and applied pharmacology.

[26]  M. Brand,et al.  Degradation of an intramitochondrial protein by the cytosolic proteasome , 2010, Journal of Cell Science.

[27]  H. Jaeschke,et al.  Mechanism of protection by metallothionein against acetaminophen hepatotoxicity. , 2010, Toxicology and applied pharmacology.

[28]  C. Zwingmann,et al.  Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N‐acetylcysteine , 2010, Hepatology.

[29]  A. Dodoo,et al.  RESEARCH ARTICLE Open Access Research article Genetic polymorphisms in MDR1, CYP3A4 and , 2022 .

[30]  S. Manabe,et al.  Sensitivity of Liver Injury in Heterozygous Sod2 Knockout Mice Treated with Troglitazone or Acetaminophen , 2009, Toxicologic pathology.

[31]  Robert A. Harris,et al.  Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[32]  Neil Kaplowitz,et al.  Role of JNK Translocation to Mitochondria Leading to Inhibition of Mitochondria Bioenergetics in Acetaminophen-induced Liver Injury* , 2008, Journal of Biological Chemistry.

[33]  D. Nicholls,et al.  ‘Mild Uncoupling’ does not decrease mitochondrial superoxide levels in cultured cerebellar granule neurons but decreases spare respiratory capacity and increases toxicity to glutamate and oxidative stress , 2007, Journal of neurochemistry.

[34]  A. Cassard-Doulcier,et al.  UCP2 is a mitochondrial transporter with an unusual very short half‐life , 2007, FEBS letters.

[35]  H. Jaeschke,et al.  Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  Y. Surh,et al.  Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. , 2006, Journal of biochemistry and molecular biology.

[37]  Robert A. Harris,et al.  Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation. , 2006, The Biochemical journal.

[38]  C. Sluse-Goffart,et al.  Mitochondrial UCPs: new insights into regulation and impact. , 2006, Biochimica et biophysica acta.

[39]  M. Holness,et al.  Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases , 2006, Archives of physiology and biochemistry.

[40]  H. Jaeschke,et al.  Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[41]  H. Jaeschke,et al.  Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  H. Jaeschke,et al.  Peroxynitrite Is a Critical Mediator of Acetaminophen Hepatotoxicity in Murine Livers: Protection by Glutathione , 2002, Journal of Pharmacology and Experimental Therapeutics.

[43]  D. Laskin,et al.  Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. , 2002, Toxicology and applied pharmacology.

[44]  H. Jaeschke,et al.  Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  K. Muldrew,et al.  Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[46]  Y. Liu,et al.  Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. , 1999, The Journal of pharmacology and experimental therapeutics.

[47]  H. Jaeschke,et al.  Use of isolated perfused organs in hypoxia and ischemia/reperfusion oxidant stress. , 1990, Methods in enzymology.